Bicara Therapeutics Inc.

BCAX
$24.63 (+ $0.87 + 3.66%)
Last updated: 2026-08-13 05:58 UTC
BCAX Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS0554771032
CUSIP055477103
Market Price24.63
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio3.26
EPS5.38
Market Cap$961.4M
Book Value7.38
Price to Book2.38
BetaN/A
52w High19.75
52w Low7.8
Next Earnings DateN/A

Bicara Therapeutics Inc. trades under ticker BCAX on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US0554771032, CUSIP 055477103. Also searched as Bicara Therapeutics.

Related researchBCAX stock priceBCAX share price055477103Bicara Therapeutics stockBicara Therapeutics share price
About the Company
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Price History